Literature DB >> 11162142

Hematologically important mutations: X-linked chronic granulomatous disease (second update).

P G Heyworth1, J T Curnutte, J Rae, D Noack, D Roos, E van Koppen, A R Cross.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162142     DOI: 10.1006/bcmd.2000.0347

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  22 in total

1.  Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.

Authors:  Jacinta Bustamante; Andres A Arias; Guillaume Vogt; Capucine Picard; Lizbeth Blancas Galicia; Carolina Prando; Audrey V Grant; Christophe C Marchal; Marjorie Hubeau; Ariane Chapgier; Ludovic de Beaucoudrey; Anne Puel; Jacqueline Feinberg; Ethan Valinetz; Lucile Jannière; Céline Besse; Anne Boland; Jean-Marie Brisseau; Stéphane Blanche; Olivier Lortholary; Claire Fieschi; Jean-François Emile; Stéphanie Boisson-Dupuis; Saleh Al-Muhsen; Bruce Woda; Peter E Newburger; Antonio Condino-Neto; Mary C Dinauer; Laurent Abel; Jean-Laurent Casanova
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Towards routine screening of rare genetic diseases: the example of chronic granulomatous disease.

Authors:  Marie José Stasia
Journal:  J Mol Diagn       Date:  2010-03-19       Impact factor: 5.568

Review 3.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

4.  Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.

Authors:  Yuka Okura; Masafumi Yamada; Futoshi Kuribayashi; Ichiro Kobayashi; Tadashi Ariga
Journal:  J Clin Immunol       Date:  2015-02-10       Impact factor: 8.317

5.  Dobzhansky-Muller incompatibilities in protein evolution.

Authors:  Alexey S Kondrashov; Shamil Sunyaev; Fyodor A Kondrashov
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

6.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

7.  Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.

Authors:  Harry R Hill; Nancy H Augustine; Robert J Pryor; Gudrun H Reed; Joshua D Bagnato; Anne E Tebo; Jeffrey M Bender; Brian M Pasi; Javier Chinen; I Celine Hanson; Martin de Boer; Dirk Roos; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

8.  Identification of a conserved Rac-binding site on NADPH oxidases supports a direct GTPase regulatory mechanism.

Authors:  Yu-Ya Kao; Davide Gianni; Benjamin Bohl; Ross M Taylor; Gary M Bokoch
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

Review 9.  Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases.

Authors:  Gary M Bokoch; Becky Diebold; Jun-Sub Kim; Davide Gianni
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 10.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.